How Immunotherapy Can Improve Survival for PD-L1 Mesothelioma Patients
Research, Treatment
By: Devin Golden
December 30, 2020
PD-L1 is an acronym for “programmed death-ligand 1.” The grim name is fitting, as this cancerous protein is linked to mesothelioma. It’s also connected to poor prognosis,...
Read Post